Udit Chander1, Rebecca J Leeman-Neill1, Govind Bhagat2. 1. Department of Pathology and Cell Biology, Columbia University Medical Center, 630 West 168th Street, New York, NY, 10032, USA. 2. Department of Pathology and Cell Biology, Columbia University Medical Center, 630 West 168th Street, New York, NY, 10032, USA. gb96@cumc.columbia.edu.
Abstract
PURPOSE OF REVIEW: To provide an update on the pathogenesis of enteropathy-associated T cell lymphoma (EATL) and its relationship with refractory celiac disease (RCD), in light of current knowledge of immune, genetic, and environmental factors that promote neoplastic transformation of intraepithelial lymphocytes (IELs). RECENT FINDINGS: EATL frequently evolves from RCD type II (RCD II) but can occur "de novo" in individuals with celiac disease. Recurrent activating mutations in members of the JAK/STAT pathway have been recently described in EATL and RCD II, which suggests deregulation of cytokine signaling to be an early event in lymphomagenesis. Intraepithelial T cells are presumed to be the cell of origin of EATL (and RCD II). Recent in vitro molecular and phenotypic analyses and in vivo murine studies, however, suggest an origin of RCD II from innate IELs (NK/T cell precursors), which could also be the cell of origin of RCD II-derived EATL. The immune microenvironment of the small intestinal mucosa in celiac disease fosters the development of EATL, often in a multistep pathway.
PURPOSE OF REVIEW: To provide an update on the pathogenesis of enteropathy-associated T cell lymphoma (EATL) and its relationship with refractory celiac disease (RCD), in light of current knowledge of immune, genetic, and environmental factors that promote neoplastic transformation of intraepithelial lymphocytes (IELs). RECENT FINDINGS: EATL frequently evolves from RCD type II (RCD II) but can occur "de novo" in individuals with celiac disease. Recurrent activating mutations in members of the JAK/STAT pathway have been recently described in EATL and RCD II, which suggests deregulation of cytokine signaling to be an early event in lymphomagenesis. Intraepithelial T cells are presumed to be the cell of origin of EATL (and RCD II). Recent in vitro molecular and phenotypic analyses and in vivo murine studies, however, suggest an origin of RCD II from innate IELs (NK/T cell precursors), which could also be the cell of origin of RCD II-derived EATL. The immune microenvironment of the small intestinal mucosa in celiac disease fosters the development of EATL, often in a multistep pathway.
Authors: Pavlina Cejkova; Andreas Zettl; Anne K Baumgärtner; Andreas Chott; German Ott; Hans Konrad Müller-Hermelink; Petr Starostik Journal: Virchows Arch Date: 2005-03-09 Impact factor: 4.064
Authors: Sara L Colpitts; Thomas A Stoklasek; Courtney R Plumlee; Joshua J Obar; Caiying Guo; Leo Lefrançois Journal: J Immunol Date: 2012-02-10 Impact factor: 5.422
Authors: Jennifer M L Tjon; Wieke H M Verbeek; Yvonne M C Kooy-Winkelaar; Binh H Nguyen; Arno R van der Slik; Allan Thompson; Mirjam H M Heemskerk; Marco W J Schreurs; Liesbeth H A Dekking; Chris J Mulder; Jeroen van Bergen; Frits Koning Journal: Blood Date: 2008-09-24 Impact factor: 22.113
Authors: Wieke H M Verbeek; Marije S Goerres; B Mary E von Blomberg; Joost J Oudejans; Petra E T Scholten; Muhammed Hadithi; Abdul Al-Toma; Marco W J Schreurs; Chris J J Mulder Journal: Clin Immunol Date: 2007-11-26 Impact factor: 3.969
Authors: A Chott; W Haedicke; I Mosberger; M Födinger; K Winkler; C Mannhalter; H K Müller-Hermelink Journal: Am J Pathol Date: 1998-11 Impact factor: 4.307
Authors: R L J van Wanrooij; D de Jong; A W Langerak; B Ylstra; H F van Essen; D A M Heideman; H J Bontkes; C J J Mulder; G Bouma Journal: BMJ Open Gastroenterol Date: 2015-06-09
Authors: M-L Nairismägi; J Tan; J Q Lim; S Nagarajan; C C Y Ng; V Rajasegaran; D Huang; W K Lim; Y Laurensia; G C Wijaya; Z M Li; I Cutcutache; W L Pang; S Thangaraju; J Ha; L P Khoo; S T Chin; S Dey; G Poore; L H C Tan; H K M Koh; K Sabai; H-L Rao; K L Chuah; Y-H Ho; S-B Ng; S-S Chuang; F Zhang; Y-H Liu; T Pongpruttipan; Y H Ko; P-L Cheah; N Karim; W-J Chng; T Tang; M Tao; K Tay; M Farid; R Quek; S G Rozen; P Tan; B T Teh; S T Lim; S-Y Tan; C K Ong Journal: Leukemia Date: 2016-02-08 Impact factor: 11.528
Authors: M Uhde; X Yu; A Bunin; C Brauner; S K Lewis; B Lebwohl; S Krishnareddy; A Alaedini; B Reizis; S Ghosh; P H Green; G Bhagat Journal: Clin Exp Immunol Date: 2020-01-27 Impact factor: 4.330